Director Zhao Wangsheng, a microbiology expert from Jiangsu Provincial People’s Hospital, and his delegation paid a visit to our company.


Release Date:

2012-03-20

On March 17–18, accompanied by Mr. Lin Huaqing, Chairman of the company, and Director Yin Hong of the Eastern Region, a delegation comprising Associate Chief Physician Zhao Wangsheng, a microbiology expert from the Department of Laboratory Medicine at Jiangsu Provincial People’s Hospital; Director Wu from the Department of Laboratory Medicine at Lianyungang Municipal People’s Hospital; Director Chen from the Department of Laboratory Medicine at Taizhou First Hospital; Director Liu from Dafeng Municipal People’s Hospital; and Director Wang from Jianhu County Hospital, paid a visit to our company to provide guidance. They conducted a detailed on-site inspection of our R&D and production processes, commended our efforts to reduce costs for hospitals through domestically produced bacterial identification and blood culture equipment—thereby delivering greater benefits to patients—and expressed strong approval. They also offered suggestions for further advancing our technology and catching up with comparable imported products.

On March 17–18, accompanied by Mr. Lin Huaqing, Chairman of the company, and Director Yin Hong of the Eastern Region, a delegation comprising Associate Chief Physician Zhao Wangsheng, a microbiology expert from the Department of Laboratory Medicine at Jiangsu Provincial People’s Hospital; Director Wu from the Department of Laboratory Medicine at Lianyungang Municipal People’s Hospital; Director Chen from the Department of Laboratory Medicine at Taizhou First Hospital; Director Liu from Dafeng Municipal People’s Hospital; and Director Wang from Jianhu County Hospital, paid a visit to our company to provide guidance. They conducted a thorough on-site inspection of our R&D and production processes, commended our efforts to reduce costs for hospitals through domestically produced bacterial identification and blood culture equipment—thereby delivering greater benefits to patients—and offered high praise. They also put forward numerous valuable recommendations aimed at further advancing our capabilities and surpassing comparable imported products.